Keywords: msd, chibret, boosts, french, investment, subsidiary, drug

MSD Chibret Boosts French Investment

Article | 22 July 1998

Print This

MSD Chibret, the French subsidiary of US drug major Merck & Co, is toinvest 650 million French francs ($108.8 million) to build a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in